Management of Coronary Artery Spasm
- PMID: 37456765
- PMCID: PMC10345953
- DOI: 10.15420/ecr.2022.47
Management of Coronary Artery Spasm
Abstract
Calcium channel blockers (CCBs) are the first-line treatment for coronary artery spasm (CAS). When CAS-related angina symptoms are not well controlled by CCB therapy, long-acting nitrates or (where available) nicorandil can be added as second-line medications. In the case of CAS refractory to standard treatments, several other alternative drugs and interventions have been proposed, including the Rho-kinase inhibitor fasudil, anti-adrenergic drugs, neural therapies and percutaneous coronary interventions. In patients with syncope or cardiac arrest caused by CAS-related tachyarrhythmias, or even bradyarrhythmias, implantation of an ICD or pacemaker, respectively, should be considered according to the risk of recurrence and efficacy of vasodilator therapy.
Keywords: Coronary artery spasm; treatment; variant angina; vasospastic angina.
Copyright © 2023, Radcliffe Cardiology.
Conflict of interest statement
Disclosures: GAL and HS are on the European Cardiology Review editorial board; this did not influence peer review. The authors have no other conflicts of interest to declare.
Figures
References
-
- Maseri A, Mimmo R, Chierchia S et al. Coronary spasm as a cause of acute myocardial ischemia in man. Am Heart J. 1975;68:625–33. doi: 10.1378/chest.68.5.625. - DOI
Publication types
LinkOut - more resources
Full Text Sources